Hydrochlorothiazide
Brand names: HydroSaluric
Hydrochlorothiazide is an oral thiazide diuretic; although coded here under urology, its principal uses are hypertension and oedema, and within renal/urological practice it is used to reduce urinary calcium excretion in recurrent calcium stone formers.
The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.
The licensed dosing — for the medicine's licensed uses, which may differ from this page's — is on Hydrochlorothiazide.
Clinical monograph
How it works
It inhibits the sodium-chloride cotransporter in the distal convoluted tubule, increasing sodium and water loss while paradoxically enhancing distal calcium reabsorption, which lowers urinary calcium.
Prescribing in practice
- It can cause clinically important electrolyte disturbance, notably hyponatraemia and hypokalaemia, so check electrolytes before starting and during treatment, particularly in the elderly.
- Thiazides raise serum urate and can precipitate gout, and may unmask or worsen glucose intolerance.
- Efficacy as a diuretic falls in significant renal impairment, where a loop diuretic is usually preferred.
Monitoring
Monitor urea and electrolytes (especially sodium and potassium), renal function, and where relevant urate and glucose.
Counselling the patient
- Take in the morning to avoid night-time passing of urine.
- Report persistent dizziness, muscle cramps, marked thirst or confusion, which may indicate salt imbalance.
Evidence & guidelines
Thiazide and thiazide-like diuretics are well established for hypertension and, per stone-prevention guidance, reduce recurrence in hypercalciuric calcium stone formers.
Reference: EAU Urolithiasis Guidelines 2024; AUA Stone Disease Guidelines 2019; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Framingham Risk Score · Cardiovascular Risk
- SCORE2-Diabetes 10-Year CVD Risk in Type 2 Diabetes · Cardiovascular Risk
- PFO-Associated Stroke Causal Likelihood (PASCAL) Classification · Stroke Prevention
- PCP-HF Risk Score (Pooled Cohort Equations to Prevent Heart Failure) · Heart Failure Prevention
- CHADS-65 Score for Atrial Fibrillation · Atrial Fibrillation
- ACC/AHA Pooled Cohort Equations (ASCVD Risk) · Cardiovascular Risk